1. Home
  2. SANM vs TLX Comparison

SANM vs TLX Comparison

Compare SANM & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANM
  • TLX
  • Stock Information
  • Founded
  • SANM 1980
  • TLX 2015
  • Country
  • SANM United States
  • TLX Australia
  • Employees
  • SANM N/A
  • TLX N/A
  • Industry
  • SANM Electrical Products
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SANM Technology
  • TLX Health Care
  • Exchange
  • SANM Nasdaq
  • TLX Nasdaq
  • Market Cap
  • SANM 4.9B
  • TLX 5.8B
  • IPO Year
  • SANM 1993
  • TLX N/A
  • Fundamental
  • Price
  • SANM $85.72
  • TLX $19.50
  • Analyst Decision
  • SANM Hold
  • TLX Strong Buy
  • Analyst Count
  • SANM 2
  • TLX 1
  • Target Price
  • SANM $80.50
  • TLX $22.00
  • AVG Volume (30 Days)
  • SANM 521.1K
  • TLX 18.5K
  • Earning Date
  • SANM 01-27-2025
  • TLX 01-01-0001
  • Dividend Yield
  • SANM N/A
  • TLX N/A
  • EPS Growth
  • SANM N/A
  • TLX N/A
  • EPS
  • SANM 4.09
  • TLX 0.09
  • Revenue
  • SANM $7,699,878,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • SANM $10.49
  • TLX N/A
  • Revenue Next Year
  • SANM $6.94
  • TLX N/A
  • P/E Ratio
  • SANM $21.66
  • TLX $217.91
  • Revenue Growth
  • SANM N/A
  • TLX 80.92
  • 52 Week Low
  • SANM $57.52
  • TLX $14.01
  • 52 Week High
  • SANM $91.12
  • TLX $20.00
  • Technical
  • Relative Strength Index (RSI)
  • SANM 50.38
  • TLX N/A
  • Support Level
  • SANM $88.96
  • TLX N/A
  • Resistance Level
  • SANM $91.12
  • TLX N/A
  • Average True Range (ATR)
  • SANM 2.74
  • TLX 0.00
  • MACD
  • SANM -0.22
  • TLX 0.00
  • Stochastic Oscillator
  • SANM 52.42
  • TLX 0.00

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue primarily in the United States, China, and Mexico, but has a presence around the world.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: